An in vitro culture system of chicken primordial germ cells (PGCs) has been recently developed, but the growth factor involved in the proliferation of PGCs is largely unknown. In the present study, we investigated the growth effects of chicken stem cell factor (chSCF) on the in vitro proliferation of chicken PGCs. We established two feeder cell lines (buffalo rat liver cells; BRL cells) that stably express the putative secreted form of chSCF (chSCF1-BRL) and membrane bound form of chSCF (chSCF2-BRL). Cultured PGC lines were incubated on chSCF1 or chSCF2-BRL feeder cells with fibroblast growth factor 2 (FGF2), and growth effects of each chSCF isoform were investigated. The in vitro proliferation rate of the PGCs cultured on chSCF2-BRL at 20 days of culture was more than threefold higher than those cultured on chSCF1-BRL cells and more than fivefold higher than those cultured on normal BRL cells. Thus, use of chSCF2-BRL feeder layer was effective for in vitro proliferation of chicken PGCs. However, the acceleration of PGC proliferation on chSCF2-BRL was not observed without FGF2, suggesting that chSCF2 would act as a proliferation co-factor of FGF2. We transferred the PGCs cultured on chSCF2-BRL cells to recipient embryos, generated germline chimeric chickens and assessed the germline competency of cultured PGCs by progeny test. Donor-derived progenies were obtained, and the frequency of germline transmission was 3.39%. The results of this study demonstrate that chSCF2 induces hyperproliferation of chicken PGCs retaining germline competency in vitro in cooperation with FGF2.
An in vitro culture system of chicken primordial germ cells (PGCs) has been recently developed, but the growth factor involved in the proliferation of PGCs is largely unknown. In the present study, we investigated the growth effects of chickenstem cell factor (chSCF) on the in vitro proliferation of chicken PGCs. We established two feeder cell lines (buffalo rat liver cells; BRL cells) that stably express the putative secreted form of chSCF (chSCF1-BRL) and membrane bound form of chSCF (chSCF2-BRL). Cultured PGC lines were incubated on chSCF1 or chSCF2-BRL feeder cells with fibroblast growth factor 2 (FGF2), and growth effects of each chSCF isoform were investigated. The in vitro proliferation rate of the PGCs cultured on chSCF2-BRL at 20 days of culture was more than threefold higher than those cultured on chSCF1-BRL cells and more than fivefold higher than those cultured on normal BRL cells. Thus, use of chSCF2-BRL feeder layer was effective for in vitro proliferation of chicken PGCs. However, the acceleration of PGC proliferation on chSCF2-BRL was not observed without FGF2, suggesting that chSCF2 would act as a proliferation co-factor of FGF2. We transferred the PGCs cultured on chSCF2-BRL cells to recipient embryos, generated germline chimeric chickens and assessed the germline competency of cultured PGCs by progeny test. Donor-derived progenies were obtained, and the frequency of germline transmission was 3.39%. The results of this study demonstrate that chSCF2 induces hyperproliferation of chicken PGCs retaining germline competency in vitro in cooperation with FGF2.
Primordial germ cells (PGCs) act as the precursor of gametes and can transmit genetic information to the next
generation through fertilization. In chickens, PGCs are efficient tools both for the cryopreservation of avian
genetic resources and the production of transgenic chickens. In 2006, van de Lavoir et al.
developed an efficient culture method for chicken PGCs using culture media containing basic fibroblast growth
factor (bFGF, also known as FGF2), stem cell factor (SCF), and leukemia inhibitory factor [1]. These cultured PGCs differentiated into functional gametes when transplanted into recipient
embryos and could be genetically modified. A recent study showed that FGF2 was one of the key factors involved
in vitro proliferation of chicken PGCs [2], and the
effectiveness of a PGC culture medium containing FGF2 was confirmed by several studies [3,4,5,6]. However, the growth factors involved in vitro proliferation
of chicken PGCs other than FGF2 are largely unknown. Thus, identification of another growth factor that support
the in vitro proliferation of chicken PGCs would contribute to the optimization of culture
conditions.In mice, c-KIT, a receptor of SCF, is expressed on the surface of PGCs. SCF is produced by gonadal somatic cells,
and the interaction between c-KIT and SCF is required for germ cell proliferation, anti-apoptosis and migration
[7,8,9,10,11,12]. Based on these data, SCF has been used as the supporting factor for the
in vitro proliferation and survival of murine PGCs [7,8,9,10]. In chickens, SCF has also been used for the culture of PGCs in various studies [1,2,3,4,5, 13, 14], but several studies insist that SCF has no
apparent function in PGC proliferation. However, those studies used mouse or human recombinant SCF proteins, and
mammalianSCF may not support the proliferation of chicken PGCs in vitro, because the amino acid
identity between mammalianSCF and chickenSCF (chSCF) is less than 60% [15, 16]. Previous reports suggest that administration of chSCF
might have a positive impact on in vitro proliferation of chicken PGCs [17, 18]. Thus, we elucidated whether chSCF is required
for in vitro culture of chicken PGCs.MammalianSCF has two isoforms: a secreted form (longer form, SCF1) and a membrane-bound form (shorter form,
SCF2) [19,20,21,22,23]. In
mice, SCF1 has a limited ability for the survival of PGC cultures, but it is not involved in proliferation [7]. Meanwhile, SCF2 enhances the in vitro proliferation of
PGCs, and use of SCF2-expressing feeder cells is effective for the long-term cultivation of murine PGCs [7,8,9,10]. Furthermore, proliferation and survival of endogenous PGCs
is inhibited in the SCF2-lacking mice (Sl/Sl mutant mice) [11]. Therefore, SCF2 is an essential factor for proliferation and survival in
vitro and in vivo. In chickens, chSCF has four reported isoforms (chSCF1–4) as
alternative splice variants (Fig. 1) [24]. The longest form of chSCF, chSCF1 (Accession
No. DQ870920, 287aa), contains a putative proteolytic cleavage site (195–196 aa) on exon 6, and thus chSCF1 is
considered the secreted form [19, 20, 24]. chSCF2 (Accession No. DQ870921, 253 aa)
lacks the exon 6 (34 aa) region, and hence chSCF2 is considered the membrane-bound form [21,22,23,24]. In addition, chSCF3 (Accession No. DQ870922, 227 aa)
lacks exon 4 (60 aa), and chSCF4 (Accession No. DQ870923, 193 aa) lacks both exon 4 and exon 6
[24]. We chose chSCF1 and chSCF2 for the in vitro growth
assay of chicken PGCs because chSCF1 and chSCF2 proteins are the closest orthologs of the secreted and
membrane-bound forms of SCF in mammals, and the amino acid identities are highly conserved in various birds.
Fig. 1.
Isoforms of chSCF. Comparison of protein structures of chSCF1–4 and the secreted and membrane-bound forms
of human SCF (hSCF1 and hSCF2, respectively). Dashed lines indicated deleted regions, and filled squares in
the C’ region indicate the transmembrane domain. Arrowheads and black arrows indicate the putative
proteolytic cleavage site and the forward and reverse primers used for Fig. 2B, respectively.
Isoforms of chSCF. Comparison of protein structures of chSCF1–4 and the secreted and membrane-bound forms
of humanSCF (hSCF1 and hSCF2, respectively). Dashed lines indicated deleted regions, and filled squares in
the C’ region indicate the transmembrane domain. Arrowheads and black arrows indicate the putative
proteolytic cleavage site and the forward and reverse primers used for Fig. 2B, respectively.
Fig. 2.
Establishment and characterization of chSCF1 or chSCF2-BRL cells. A) Schematic of the
piggyBac chSCF1 and chSCF2 expression vectors. PB, piggyBac
repetitive elements; EF1a, EF1a promoter; SV40, SV40 promoter; Neor, neomycin resistance. B)
RT-PCR analysis of chSCF1-BRL cells, chSCF2-BRL cells and normal BRL cells. The 604-bp and 502-bp bands
in the upper panel indicate chSCF1- or chSCF2-derived amplification
products, respectively, and the 503-bp band in the lower panel indicates rat
GAPDH-derived amplification products. M, Molecular size marker; 1, chSCF1-BRL cells; 2,
chSCF2-BRL cells; 3, normal BRL cells; N, no cDNA control.
The purpose of this study was to confirm the growth effects of chSCF1 or chSCF2 on chicken PGCs in
vitro using buffalo rat liver (BRL) feeder cells stably expressing chSCF1 (chSCF1-BRL) or chSCF2
(chSCF2-BRL). We showed that chSCF2-BRL cells significantly enhanced the in vitro proliferation
rate of chicken PGCs, and the hyperproliferated PGCs on chSCF2-BRL cells were retained the germline
competency.
Materials and Methods
Fertilized eggs and animal care
Fertilized eggs were obtained from White Leghorn (WL) and Barred Plymouth Rock (BPR) chickens, and were
provided by the National Agriculture and Food Research Organization Institute of Livestock and Grassland
Science (NILGS). All experiments in this study were performed in accordance with the Committee for the Care
and Use of Experimental Animals at the NILGS.
RNA extraction
Total RNA was extracted from day 19 embryonic ovaries or cultured cells using an RNeasy Plus Micro Kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s instructions. Total RNA (1 μg) was reverse
transcribed using the PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa Bio, Otsu, Shiga, Japan). The
synthesized cDNAs were used for the subsequent assays.
Establishment of feeder cells stably expressing chSCF
BRL cells were used as feeder cells (CRL-1441, provided by ATCC). BRL cells were cultured and maintained
using Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) containing 10% FBS
(Biosera, Ringmer, UK). The cDNAs of chSCF1 (Accession No. DQ870920) and
chSCF2 (Accession No. DQ870921) were isolated from the RNA of day 19 embryonic ovaries by
RT-PCR using forward (5′-ttccttatgaagaaggcacaaact-3′) and reverse (5′-cagctacacttgtagatgttcttt-3′) primers and
subcloned into pGEM-T Easy vector (Promega, Fitchburg, WI, USA). After sequencing confirmation, chSCF1 and
chSCF2 cDNAs were cloned into a commercially available vector with piggyBac transposon
(PB530A-2, System Biosciences, Mountain View, CA, USA) with an SV40 promoter-driven neomycin resistance
(Neor) gene. The schema of vector construction is illustrated in Fig. 2A. These constructs were co-transfected with a piggyBac transposase expression vector
into BRL cells using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s
instructions. After transfection, cells were selected for more than 2 weeks using 10% FBS-DMEM containing 500
μg/ml of G-418 to establish BRL cell lines stably expressing chSCF1 and chSCF2 (chSCF1-BRL and
chSCF2-BRL).Establishment and characterization of chSCF1 or chSCF2-BRL cells. A) Schematic of the
piggyBac chSCF1 and chSCF2expression vectors. PB, piggyBac
repetitive elements; EF1a, EF1a promoter; SV40, SV40 promoter; Neor, neomycin resistance. B)
RT-PCR analysis of chSCF1-BRL cells, chSCF2-BRL cells and normal BRL cells. The 604-bp and 502-bp bands
in the upper panel indicate chSCF1- or chSCF2-derived amplification
products, respectively, and the 503-bp band in the lower panel indicates ratGAPDH-derived amplification products. M, Molecular size marker; 1, chSCF1-BRL cells; 2,
chSCF2-BRL cells; 3, normal BRL cells; N, no cDNA control.
RT-PCR
To detect the chSCF isoforms in chSCF1-BRL cells or chSCF2-BRL cells, RT-PCR was performed
using TaKaRa Ex Taq Hot Start Version (TaKaRa Bio). The PCR conditions were 95C for 2 min and then 40 cycles
of 95ºC for 30 sec, 55°C for 30 sec and 72ºC for 30 sec, followed by 72ºC for 5 min. The sequences of the
primers used were as follows: 5'-gtcaaagcccagagttcctg-3', forward, and 5'-ggctggagctgctaatgaag-3', reverse,
for chSCF1 or chSCF2 and 5'-cagggctgccttctcttgtg-3', forward, and
5'-accagtggatgcagggatga-3', reverse, for ratGAPDH (Accession No. NM_017008).
Culture and maintenance of PGCs
Circulating PGCs were collected from male WL embryonic blood at Hamburger and Hamilton’s developmental stage
14 (HH14) [25]. Embryos were sexed by PCR using W chromosome-specific
primers [26], and whole blood cells containing PGCs were grown on a BRL
feeder layer. The PGC culture medium was prepared as described in previous studies with some modifications
[1, 5]. The PGC culture medium
contained KnockOut DMEM (KO-DMEM; Life Technologies), 50% BRL-conditioned KO-DMEM, 7.5% ES qualified FBS (Life
Technologies), 2.5% chicken serum (Biowest, Nuaillé, France), 2 mM GlutaMAX (Life Technologies), 1 mM sodium
pyruvate (Life Technologies), 1 × nonessential amino acids (Life Technologies), 1 × nucleosides (Millipore,
Billerica, MA, USA), 0.5 mM monothioglycerol (Wako Pure Chemical Industries, Osaka, Japan) and 5 ng/ml humanFGF2 (Wako Pure Chemical Industries). Half the volume of the culture medium was replaced every 2 days during
the culture period for PGCs, and the cultured PGCs were passaged until 90% confluence. Several male PGCs were
proliferated to large numbers, and could be maintained for more than 100 days. The established PGC lines were
used for subsequent assays.
In vitro growth assay
Cultured PGCs (1.0 × 104 cells/ml) were seeded onto proliferation-inactivated chSCF1-BRL or
chSCF2-BRL cells and subcultured for 20 days in PGC culture media containing 5 ng/ml humanFGF2. For the
control group, PGCs were cultured in a conventional culture system, namely on a normal BRL feeder layer using
PGC culture media containing 5 ng/ml humanFGF2. The experiment was repeated four times.
Immunocytochemistry
Circulating PGCs derived from HH14 embryonic blood or cultured PGCs were adhered onto a MAS-GP Type A coated
glass slide (Matsunami Glass, Osaka, Japan) and fixed with 4% paraformaldehyde for 5 min at room temperature
(RT). After several washes, cells were blocked with PBS containing 5% normal goat serum or Image-iT signal
enhancer (Life Technologies) and incubated overnight at 4ºC with primary antibodies. Then, cells were
incubated for 30 min or 1 h at RT with secondary antibodies. Subsequently, cells were counterstained with 1
µg/ml Hoechst 33342 (Dojindo, Kumamoto, Japan). Fluorescent images were captured using an Eclipse E1000
fluorescence upright microscope (Nikon, Tokyo, Japan), and these images were processed using Photoshop
Elements (Adobe Systems, San Jose, CA, USA) for trimming and overlaying. Sources and dilution of used
antibodies were as follows: rat anti-chicken vasa homolog (CVH) raised in our laboratory (1:10000) [27], mouse anti-stage specific embryonic antigen-1 (SSEA-1; 1:100,
Developmental Studies Hybridoma Bank, Iowa City, IA, USA), mouse anti-chickenc-KIT (1:500, SouthernBiotech,
Birmingham, AL, USA), goat anti-rat IgG conjugated with Alexa Fluor 488 (1:1000, Life Technologies) and goat
anti-mouse IgG or IgM conjugated with Alexa Fluor 594 (1:1000, Life Technologies).
Production of germline chimeric chickens and progeny test
PGC lines derived from WL chickens were cultured on chSCF2-BRL cells to produce germline chimeric chickens.
PGCs (1.0 × 103 cells) were injected into the dorsal aorta of HH14-16 BPR embryos. Manipulated
embryos were incubated until hatching, and the chicks were grown until sexual maturity. Male putative germline
chimeric chickens were crossed with female BPR chickens (i/i) by artificial insemination to
test the donor WL chicken (I/I)-derived spermatogenesis. White offspring
(I/i) indicated the progeny of cultured PGC (WL)-derived chicks, whereas black offspring
(i/i) indicated the progeny of recipient (BPR)-derived chicks.
Statistical analysis
Statistical differences in the proliferation rate of PGCs were calculated by the Tukey-Kramer method or
Welch’s t-test. Data were regarded as significant at P < 0.05.
Results
Establishment and characterization of chSCF-expressing feeder cells
To analyze the possible function of SCF in chicken PGCs, we attempted to isolate chicken orthologs of SCFs.
Among the four chSCF alternative splice variants, chSCF1 and chSCF2 are putative orthologs of the mammalianSCF secreted form and membrane-bound form, respectively (Fig. 1).
The cDNAs encoding chSCF1 and chSCF2 were first isolated from a day 19 embryonic ovary as 864 bp and 762 bp
genes. The chSCF1 or chSCF2expression vectors were then transfected into
BRL cells (Fig. 2A), and these cells were selected with G-418. After
selection, we examined chSCF1 and chSCF2expression in chSCF1-BRL cells and
chSCF2-BRL cells by RT-PCR. Amplification products derived from chSCF1 (604 bp) and
chSCF2 (502 bp) were detected in chSCF1-BRL cells and chSCF2-BRL cells, respectively (Fig. 2B). By contrast, chSCF1 and
chSCF2 were not expressed in normal BRL cells.
c-KIT expression in circulating and cultured PGCs
To examine the expression of the chSCF receptor c-KIT in chicken PGCs, we performed immunocytochemistry on
circulating PGCs derived from embryonic blood at HH14 and cultured PGCs. Endogenous c-KIT proteins could be
detected in the PGC-like large spheres with CVH, a pan-germ cell marker, but not in CVH-negative blood cells
(Fig. 3A). Furthermore, cultured PGCs also co-expressed CVH and c-KIT (Fig.
3B). CVH protein was localized to the cytoplasm, and c-KIT protein was localized to the cytomembrane
and cytoplasm.
Fig. 3.
Expression of c-KIT circulating and cultured chicken PGCs. A) Immunostaining of CVH (germ cell marker)
and c-KIT (receptor of chSCF) in circulating PGCs derived from HH14 embryonic blood. B) Immunostaining
of cultured PGCs stained with the same antibodies. CVH proteins were expressed in cytoplasm, and c-KIT
proteins were expressed on the cytomembrane and cytoplasm, whereas red blood cells (CVH-negative cells)
did not express CVH or c-KIT. Scale bars: 10 μm.
Expression of c-KIT circulating and cultured chicken PGCs. A) Immunostaining of CVH (germ cell marker)
and c-KIT (receptor of chSCF) in circulating PGCs derived from HH14 embryonic blood. B) Immunostaining
of cultured PGCs stained with the same antibodies. CVH proteins were expressed in cytoplasm, and c-KIT
proteins were expressed on the cytomembrane and cytoplasm, whereas red blood cells (CVH-negative cells)
did not express CVH or c-KIT. Scale bars: 10 μm.
Growth effects of chSCF isoforms
To elucidate the growth effects of chSCF1 and chSCF2 on PGCs, WL-derived PGC lines (obtained from male
embryos) were seeded onto chSCF1-BRL or chSCF2-BRL feeder layers using a PGC culture medium containing FGF2 (5
ng/ml). In vitro growth assays were started from 1.0 × 104 cells/ml of PGCs, and
the cells were cultured for 20 days. Cultured PGCs were maintained as floating or weakly adhesive cells under
every culture condition. The cultured PGCs were shaped like large spheres and had large nuclei and many lipids
in their cytoplasm, and their morphological characteristics were not different from those of normal chicken
PGCs (Fig. 4A) [5]. In addition, various diameters of cultured PGCs were
observed under every culture conditions (6–20 μm). Cultured PGCs co-expressed CVH and undifferentiated cell
marker SSEA-1 under each condition (Fig. 4B). CVH protein was
localized in the cytoplasm, and SSEA-1 was localized on the cytomembrane, respectively. Thus, the CVH and
SSEA-1 expression indicated that the cultured PGCs were maintained as germ cells in undifferentiated state.
PGCs showed significant proliferation on the chSCF2-BRL feeder layer compared with the normal BRL and
chSCF1-BRL feeder layers (P < 0.05). The cell numbers at 20 days after culture start were 1.81 ± 0.83 ×
105 cells/ml (control), 3.38 ± 0.75 × 105 cells/ml (chSCF1-BRL) and 1.06 ± 0.35 ×
106 cells/ml (chSCF2-BRL) (Fig. 5A). These data indicate that use of chSCF2-BRL cells can induce a more than fivefold increase in
proliferation of PGCs compared with conventional culture conditions. To investigate whether chSCF1 and chSCF2
are sufficient for PGC proliferation, we performed a proliferation assay using a culture medium without FGF2.
The results showed that PGCs did not sufficiently proliferate on feeder layers compared with the proliferation
observed under culture conditions with FGF2 (Fig. 5B).
Fig. 4.
Characterization of cultured PGCs. A) Morphological characteristics of PGCs cultured on chSCF1-BRL,
chSCF2-BRL, and normal BRL feeder layers at 10 days of culture. Cultured PGCs had the same morphological
characteristics as normal PGCs; they were shaped like large spheres, had large nuclei and had many
lipids in their cytoplasm. The arrows in each panel indicate the typically cultured PGCs. Scale bars: 50
μm. B) Immunofluorescence of PGCs cultured on chSCF2-BRL cells using CVH and SSEA-1 antibodies. The CVH
protein was localized in the cytoplasm, and SSEA-1 was localized on the cytomembrane. Scale bars: 10
μm.
Fig. 5.
Proliferation effects of chSCF isoforms. A) Growth curves of PGCs under several culture conditions.
PGCs (1.0 × 104 cells/ml) were seeded onto feeder cells and cultured for 20 days in PGC
culture medium containing 5 ng/ml FGF2. Data are presented as the mean ± SEM. Asterisks indicate
statistical significance based on the Tukey-Kramer method (*P < 0.05; **P < 0.01). B) PGCs (1.0 ×
104 cells/ml) were seeded onto feeder cells and cultured for 8 days using medium with or
without FGF2. Data are presented as the mean ± SEM. Asterisks indicate statistical significance based on
Welch’s t-test (*P < 0.05; **P < 0.01).
Characterization of cultured PGCs. A) Morphological characteristics of PGCs cultured on chSCF1-BRL,
chSCF2-BRL, and normal BRL feeder layers at 10 days of culture. Cultured PGCs had the same morphological
characteristics as normal PGCs; they were shaped like large spheres, had large nuclei and had many
lipids in their cytoplasm. The arrows in each panel indicate the typically cultured PGCs. Scale bars: 50
μm. B) Immunofluorescence of PGCs cultured on chSCF2-BRL cells using CVH and SSEA-1 antibodies. The CVH
protein was localized in the cytoplasm, and SSEA-1 was localized on the cytomembrane. Scale bars: 10
μm.Proliferation effects of chSCF isoforms. A) Growth curves of PGCs under several culture conditions.
PGCs (1.0 × 104 cells/ml) were seeded onto feeder cells and cultured for 20 days in PGC
culture medium containing 5 ng/ml FGF2. Data are presented as the mean ± SEM. Asterisks indicate
statistical significance based on the Tukey-Kramer method (*P < 0.05; **P < 0.01). B) PGCs (1.0 ×
104 cells/ml) were seeded onto feeder cells and cultured for 8 days using medium with or
without FGF2. Data are presented as the mean ± SEM. Asterisks indicate statistical significance based on
Welch’s t-test (*P < 0.05; **P < 0.01).
Germline transmission of cultured PGCs on chSCF2-BRL cells
To further assess whether the PGCs that hyperproliferated on chSCF2-BRL cells could differentiate into
functional gametes, we produced germline chimeric chickens following transplantation of these cells and
performed progeny tests. We analyzed male chimeric chickens, because cultured chicken PGCs could not complete
normal gametogenesis in the gonads of the opposite sex [3, 28, 29]. Three male chimeric
chickens were produced, and two chimeras were grown to sexual maturity. Two donor-derived white progenies
(I/i) were generated from one germline chimeric chicken (ID 121), and the frequency of
germline transmission was 3.39% (Fig. 6, Table 1). Thus, these data demonstrated that expanded PGCs following enhanced proliferation with
chSCF2-BRL cells could differentiate into functional spermatozoa.
Fig. 6.
Germline transmission of PGCs cultured on chSCF2-BRL cells. Donor (injected PGCs)-derived offspring
from injected PGCs cultured on chSCF2-BRL cells. The white feather chick is a WL donor PGC-derived
offspring (I/i), and the black feather chicks are recipient-derived
offspring (i/i).
Table 1.
Frequency of germline transmission of PGCs cultured with chSCF2-BRL cells
ID
Eggs set
No. of hatched chicks
No. of recipient PGC-derived chicks
(i/i)
No. of cultured PGC-derived chicks
(I/i)
% of cultured PGC-derived chicks
103
32
29
29
0
0
121
65
32
30
2
6.25
Total
97
61
59
2
3.39
Germline transmission of PGCs cultured on chSCF2-BRL cells. Donor (injected PGCs)-derived offspring
from injected PGCs cultured on chSCF2-BRL cells. The white feather chick is a WL donorPGC-derived
offspring (I/i), and the black feather chicks are recipient-derived
offspring (i/i).
Discussion
In the present study, we first demonstrated that chSCF2 positively regulates PGC proliferation in
vitro and that the hyperproliferated PGCs retained germline competency. We also clarified that the
proliferative effect of chSCF2 requires FGF2, indicating that these two cytokines functionally interact and
enhance chickenPGC proliferation.SCF is an essential cytokine for the proliferation, survival, and migration of mice PGCs, and the SCF signal is
also required for in vitro culture [7,8,9,10,11,12]. In mice, SCF1
has a limited effect on survival of PGCs, and thus SCF1 does not enhance the in vitro
proliferation of PGCs [7]. Meanwhile, use of SCF2-expressing feeder cells
is effective for long-term proliferation of mouse PGCs compared with use of medium supplemented with SCF1 [10]. In chickens, several studies reported that chSCF1 was an important
factor for proliferation or differentiation in various cells including embryonic stem cells, normal erythroid
progenitor cells and osteoblasts [30,31,32]. However, how SCF functions in chicken PGCs has been
unknown. This study revealed that c-KIT, a receptor of chSCF, was expressed in proliferative PGCs in
vivo, suggesting that chSCF functions as a growth factor that enables expansion of endogenous PGCs in
chickens. Our data showed that chSCF2-BRL feeder cells improved the in vitro proliferation rate
of chicken PGCs by fivefold compared with normal BRL feeder cells. Meanwhile, our data also demonstrated that
chSCF1-BRL feeder cells did not sufficiently supported the in vitro proliferation of chicken
PGCs, and this result was consistent with the previous studies [17, 33]. Thus, chSCF2 was considered one of the essential factor for the
in vitro proliferation of chicken PGCs. On the other hand, another group showed that SCF2
sustained the tyrosine kinase activity of the c-KIT receptor in a human myeloid cell line more than SCF1 [34]. This report and our data suggest that the chSCF2 might have more potent
or prolonged effects on PGC proliferation via c-KIT mediated growth signals compared with chSCF1.Our data demonstrated that neither chSCF1 nor chSCF2 is sufficient for PGC proliferation in conventional medium
without FGF2. Previous studies reported that FGF2 treatment was sufficient for in vitro
proliferation and survival of chicken PGCs [2, 3, 5]. Our results are consistent with these findings
and clarified that chSCF1 and chSCF2 cannot induce PGC proliferation as a substitute for FGF2. On the other
hand, we also showed that the use of chSCF2-BRL feeder cells enhanced the in vitro
proliferation rate of chicken PGCs under culture conditions that contained FGF2. These findings suggested that
chSCF2 is the proliferation co-factor of FGF2.Several studies reported that chicken PGCs cultured for a long term tend to lose their characteristics as
endogenous PGCs, including their gonadal migration activity, undifferentiated state and normal gametic
differentiation ability [5, 13]. In
the present study, we obtained live offspring derived from PGCs cultured on the chSCF2-BRL feeder layer. We
found that PGCs cultured on chSCF2-BRL cells completed differentiation into functional spermatozoa in the
recipient germline.Together, these results indicate that chSCF2 induces hyperproliferation of chicken PGCs in cooperation with
FGF2, and those hyperproliferated PGCs retain germline competency. chSCF2 has a high amino acid identity among
various birds such as the quail (98%, Coturnix japonica, AAC59934), Japanese ibis (95%,
Nipponia nippon, XP_009462259), and duck (94%, Anas platyrhynchos,
XP_012960092). Thus, this PGC culture system combined with chSCF2 and FGF2 would be useful for the in
vitro culture of PGCs derived from these birds. Furthermore, the present culture system would be
extremely valuable for the cell based systems for cryopreservation of avian genetic resources and the generation
of transgenic chickens.
Authors: K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams Journal: Cell Date: 1990-10-05 Impact factor: 41.582
Authors: D M Anderson; S D Lyman; A Baird; J M Wignall; J Eisenman; C Rauch; C J March; H S Boswell; S D Gimpel; D Cosman Journal: Cell Date: 1990-10-05 Impact factor: 41.582
Authors: D Toksoz; K M Zsebo; K A Smith; S Hu; D Brankow; S V Suggs; F H Martin; D A Williams Journal: Proc Natl Acad Sci U S A Date: 1992-08-15 Impact factor: 11.205